Varex Imaging Corp. 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Varex Imaging Corporation on March 21, 2019. The filing discloses the entry into a material definitive agreement to acquire a majority stake in Direct Conversion AB (publ), a manufacturer of linear array digital detectors, and an amendment to the Company's existing credit facility.
Key Financial Metrics and Transaction Details
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, or margins for a specific reporting period. Instead, it details the following transaction-specific financial terms:
- Acquisition Price: Aggregate purchase price of €75,200,000 for 100% of Direct Conversion shares.
- Payment Structure: €65,200,000 payable at closing; €10,000,000 held back for one year.
- Holdback Settlement: The €10,000,000 holdback may be settled in cash or Varex common stock valued at the closing trading price.
- Debt Capacity: The Credit Agreement amendment allows for up to $25,000,000 in "Specified Incremental Equivalent Debt" (subordinated debt) exempt from certain conditions.
Material Changes and Agreements
The filing reports two primary material changes:
- Share Purchase Agreement: Varex will acquire at least 90% of Direct Conversion. Closing is subject to competition authority clearance, the sale of over 90% of shares, and the election of a new board selected by Varex. The agreement may be terminated if not closed by April 30, 2019.
- Credit Agreement Amendment: Amendment No. 3 to the May 1, 2017 Credit Agreement increases the maximum consolidated total leverage ratio and senior secured leverage ratio requirements for various fiscal quarters to accommodate the transaction.
Outlook, Risks, and Contingencies
Management commentary is limited to the announcement of the acquisition. Key risks and contingencies include:
- Closing Conditions: The transaction is contingent on regulatory approvals and the successful sale of the requisite share percentage.
- Termination Risk: The agreement includes a "drop-dead" date of April 30, 2019, after which any party may terminate.
- Equity Dilution: Up to €10,000,000 of the purchase price may be paid in unregistered common stock, subject to exemptions under Section 4(a)(2) of the Securities Act.
Investor Verification Checklist
- Verify the status of competition authority clearances required for the Direct Conversion acquisition.
- Confirm whether the transaction closes before the April 30, 2019 termination deadline.
- Monitor the impact of the increased leverage ratios on future borrowing capacity and covenant compliance.
- Assess the potential dilution impact if the €10,000,000 holdback is settled in Varex common stock.